Frontage Holdings Corporation (1521.HK)
Frontage Holdings Corporation provides drug discovery, drug development, pharmaceutical product development, and laboratory testing services to pharmaceutical, biotechnology, and agrochemical companies.
1.15-0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-23.3%
The outlook
Frontage Holdings Corporation currently reads as leaning bullish based on above its 50- & 200-day averages, 47% of the way from its 52-week low to high, avg target -15% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range47% of the way from its 52-week low to high
Price targetAvg target -15% vs current price
Analyst price target
~12-month · 2 analysts0.97average target-15.4% vs now
Now 1.15
Low 0.94High 1.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$2.33B
52-wk high
1.68
52-wk low
0.68
50-day avg
0.99
200-day avg
1.04
Trailing P/E
38.3